Eyenovia Inc (EYEN)
0.74
-0.01
(-1.32%)
USD |
NASDAQ |
May 20, 16:00
0.74
0.00 (0.00%)
After-Hours: 07:27
Eyenovia Cash from Financing (Quarterly): 3.133M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.133M |
| December 31, 2023 | 0.6143M |
| September 30, 2023 | 10.78M |
| June 30, 2023 | 5.001M |
| March 31, 2023 | 3.400M |
| December 31, 2022 | 3.307M |
| September 30, 2022 | 2.872M |
| June 30, 2022 | -0.3185M |
| March 31, 2022 | 15.65M |
| December 31, 2021 | 12.29M |
| September 30, 2021 | -0.189M |
| June 30, 2021 | 7.902M |
| March 31, 2021 | 1.453M |
| December 31, 2020 | 0.0974M |
| September 30, 2020 | 14.69M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.5668M |
| March 31, 2020 | 5.515M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 12.96M |
| June 30, 2019 | 0.0679M |
| March 31, 2019 | 0.4839M |
| December 31, 2018 | 2.818M |
| September 30, 2018 | 0.0565M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 24.74M |
| December 31, 2017 | -0.1564M |
| September 30, 2017 | 6.76M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.3185M
Minimum
Jun 2022
15.65M
Maximum
Mar 2022
4.989M
Average
3.220M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Alpine Immune Sciences Inc | 19.35M |
| Lantern Pharma Inc | 0.0547M |
| Oragenics Inc | 1.653M |
| MAIA Biotechnology Inc | 4.717M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.892M |
| Cash from Investing (Quarterly) | -0.1141M |
| Free Cash Flow | -29.93M |
| Free Cash Flow Per Share (Quarterly) | -0.2147 |
| Free Cash Flow to Equity (Quarterly) | -10.63M |
| Free Cash Flow Yield | -93.37% |